Gu L, Casserly D, Brady G, Carpenter S, Bracken AP, Fitzgerald KA, Unterholzner L, Bowie AG., Myeloid cell nuclear differentiation antigen controls the pathogen-stimulated type I interferon cascade in human monocytes by transcriptional regulation of IRF7., Nature communications, 13, (1), 2022, p14 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Brien GL, Bressan RB, Monger C, Gannon D, Lagan E, Doherty AM, Healy E, Neikes H, Fitzpatrick DJ, Deevy O, Grant V, Marqués-Torrejón MA, Alfazema N, Pollard SM, Bracken AP., Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells., Nature Genetics, 53, (8), 2021, p1221 - 1232,
Journal Article,
PUBLISHED
TARA - Full Text
|
Lynch, S.M. and Russell, N.M. and Barron, S. and Wang, C.-J.A. and Loughman, T. and Dynoodt, P. and Fender, B. and Lopez-Ruiz, C. and O'Grady, A. and Sheehan, K.M. and Fay, J. and Amberger-Murphy, V. and Saha, A. and Klinger, R. and Gonzalez, C.A. and Al-Attar, N. and Rahman, A. and O'Leary, D. and Lanigan, F.T. and Bracken, A.P. and Crown, J. and Kelly, C.M. and O'Connor, D.P. and Gallagher, W.M., Prognostic value of the 6-gene OncoMasTR test in hormone receptorâ"positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors, European Journal of Cancer, 152, 2021, p78-89 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Huang, Z. and Liang, N. and Goñi, S. and Damdimopoulos, A. and Wang, C. and Ballaire, R. and Jager, J. and Niskanen, H. and Han, H. and Jakobsson, T. and Bracken, A.P. and Aouadi, M. and Venteclef, N. and Kaikkonen, M.U. and Fan, R. and Treuter, E., The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages, Molecular Cell, 81, (5), 2021, p953-968.e9 ,
Notes: [cited By 10],
Journal Article,
PUBLISHED
DOI
|
Glancy, E. and Ciferri, C. and Bracken, A.P., Structural basis for PRC2 engagement with chromatin, Current Opinion in Structural Biology, 67, 2020, p135-144 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Lanigan F, Gallagher WM and Bracken AP., 'A method of predicting risk of recurrence of cancer', TCD and UCD, US 10,557,175, 2020, Jointly owned by TCD and UCD,
Notes: [The invention relates to a method of predicting the risk of tumour recurrence in a subject. Specifically, the invention relates to a method of predicting the risk of early-stage node -negative breast cancer, prostate cancer and other tumour recurrence],
Patent,
GRANTED
URL
|
Healy E, Mucha M, Glancy E, Fitzpatrick DJ, Conway E, Neikes HK, Monger C, Van Mierlo G, Baltissen MP, Koseki Y, Vermeulen M, Koseki H, and Bracken AP. , PRC2.1 and PRC2.2 synergize to co-ordinate H3K27 tri-methylation, Molecular Cell, 2019, p437-452.e6 ,
Journal Article,
PUBLISHED
DOI
|
Deevy O and Bracken AP., PRC2 functions in development and congenital disorders, Development, 146, (19), 2019, pdev181354 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Bracken AP, Brien GL and Verrijzer CP., Dangerous Liaisons: Interplay between SWI/SNF, NuRD and Polycomb in Chromatin Regulation and Cancer. , Genes & Development, 33, 2019, p1 - 24,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Lanigan F, Gallagher WM and Bracken AP., 'A method of predicting risk of recurrence of cancer,', TCD and UCD, EP3194621, 2019, Jointly owned by TCD and UCD,
Notes: [The invention relates to a method of predicting the risk of tumour recurrence in a subject. Specifically, the invention relates to a method of predicting the risk of early-stage node -negative breast cancer, prostate cancer and other tumour recurrence],
Patent,
GRANTED
URL
|
|